|
1
|
Tang J, Feng Y, Tsao S, Wang N, Curtain R
and Wang Y: Berberine and Coptidis rhizoma as novel antineoplastic
agents: A review of traditional use and biomedical investigations.
J Ethnopharmacol. 126:5–17. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Choi UK, Kim MH and Lee NH: Optimization
of antibacterial activity by Gold–Thread (Coptidis Rhizoma Franch)
against Streptococcus mutans using evolutionary operation-factorial
design technique. J Microbiol Biotechnol. 17:1880–1884.
2007.PubMed/NCBI
|
|
3
|
Ye X, Feng Y, Tong Y, Ng KM, Tsao S, Lau
GK, Sze C, Zhang Y, Tang J, Shen J and Kobayashi S:
Hepatoprotective effects of Coptidis rhizoma aqueous extract on
carbon tetrachloride-induced acute liver hepatotoxicity in rats. J
Ethnopharmacol. 124:130–136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin SJ, Chen CS, Lin SS, Chou MY, Shih HC,
Lee IP, Kao CT, Ho CC, Chen FL, Ho YC, et al: In vitro
anti-microbial and in vivo cytokine modulating effects of different
prepared Chinese herbal medicines. Food Chem Toxicol. 44:2078–2085.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim HY, Shin HS, Park H, Kim YC, Yun YG,
Park S, Shin HJ and Kim K: In vitro inhibition of coronavirus
replications by the traditionally used medicinal herbal extracts,
Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and
Phellodendron cortex. J Clin Virol. 41:122–128. 2008. View Article : Google Scholar
|
|
6
|
Enk R, Ehehalt R, Graham JE, Bierhaus A,
Remppis A and Greten HJ: Differential effect of Rhizoma coptidis
and its main alkaloid compound berberine on TNF-alpha induced
NFkappaB translocation in human keratinocytes. J Ethnopharmacol.
109:170–175. 2007. View Article : Google Scholar
|
|
7
|
Tse WP, Che CT, Liu K and Lin ZX:
Evaluation of the anti-proliferative properties of selected
psoriasis-treating Chinese medicines on cultured HaCaT cells. J
Ethnopharmacol. 108:133–141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim YJ, Kang SA, Hong MS, Park HJ, Kim MJ,
Park HJ and Kim HK: Coptidis rhizoma induces apoptosis in human
colorectal cancer cells SNU-C4. Am J Chin Med. 32:873–882. 2004.
View Article : Google Scholar
|
|
9
|
Serafim TL, Oliveira PJ, Sardao VA,
Perkins E, Parke D and Holy J: Different concentrations of
berberine result in distinct cellular localization patterns and
cell cycle effects in a melanoma cell line. Cancer Chemother
Pharmacol. 61:1007–1018. 2008. View Article : Google Scholar
|
|
10
|
Tsai JC, Tsai S and Chang WC: Effect of
ethanol extracts of three Chinese medicinal plants with
anti-diarrheal properties on ion transport of the rat intestinal
epithelia. J Pharmacol Sci. 94:60–66. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Derosa G, Maffioli P and Cicero AF:
Berberine on metabolic and cardiovascular risk factors: An analysis
from preclinical evidences to clinical trials. Expert Opin Biol
Ther. 12:1113–1124. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yokozawa T, Ishida A, Kashiwada Y, Cho EJ,
Kim HY and Ikeshiro Y: Coptidis Rhizoma: Protective effects against
peroxynitrite-induced oxidative damage and elucidation of its
active components. J Pharm Pharmacol. 56:547–556. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gulfraz M, Mehmood S, Ahmad A, Fatima N,
Praveen Z and Williamson EM: Comparison of the antidiabetic
activity of Berberis lyceum root extract and berberine in
alloxan-induced diabetic rats. Phytother Res. 22:1208–1212. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yokozawa T, Ishida A, Cho EJ and Nakagawa
T: The effects of Coptidis Rhizoma extract on a
hypercholesterolemic animal model. Phytomedicine. 10:17–22. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yin J, Zhang H and Ye J: Traditional
chinese medicine in treatment of metabolic syndrome. Endocr Metab
Immune Disord Drug Targets. 8:99–111. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo Y, Wang QZ, Li FM, Jiang X, Zuo YF and
Wang L: Biochemical pathways in the antiatherosclerotic effect of
berberine. Chin Med J (Engl). 121:1197–1203. 2008.
|
|
17
|
Han YL, Yu HL, Lin D, Meng XL, Zhou ZY, Yu
Q, Zhang XY, Wang FJ and Guo C: In vitro inhibition of Huanglian
[Rhizoma coptidis (L.)] and its six active alkaloids on six
cyXto-chrome P450 isoforms in human liver microsomes. Phytother
Res. 25:1660–1665. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim JM, Jung HA, Choi JS and Lee NG:
Identification of anti-inflammatory target genes of Rhizoma
coptidis extract in lipopolysaccharide-stimulated RAW264.7 murine
macrophage-like cells. J Ethnopharmacol. 130:354–362. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Q, Zhang M, Liang B, Shirwany N, Zhu
Y and Zou MH: Activation of AMP-activated protein kinase is
required for berberine-induced reduction of atherosclerosis in
mice: The role of uncoupling protein 2. PLoS One. 6:e254362011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang C, Li J, Lv X, Zhang M, Song Y, Chen
L and Liu Y: Ameliorative effect of berberine on endothelial
dysfunction in diabetic rats induced by high-fat diet and
streptozotocin. Eur J Pharmacol. 620:131–137. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Grycová L, Dostál J and Marek R:
Quaternary protoberberine alkaloids. Phytochemistry. 68:150–175.
2007. View Article : Google Scholar
|
|
22
|
Zhang M and Chen L: Berberine in type 2
diabetes therapy: A new perspective for an old antidiarrheal drug?
Acta Pharmaceutica Sinica B. 2:379–386. 2012. View Article : Google Scholar
|
|
23
|
Ma BL, Ma YM, Gao CL, Wu JS, Qiu FR, Wang
CH and Wang X: Lipopolysaccharide increased the acute toxicity of
the Rhizoma coptidis extract in mice by increasing the systemic
exposure to Rhizoma coptidis alkaloids. J Ethnopharmacol.
138:169–174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu S, Pang XY, Deng YX, Liu L, Liang Y,
Liu XD, Xie L, Wang GJ and Wang XT: A sensitive and specific liquid
chromatography mass spectrometry method for simultaneous
determination of berberine, palmatine, coptisine, epiberberine and
jatrorrhizine from Coptidis Rhizoma in rat plasma. Int J Mass
Spectrom. 268:30–37. 2007. View Article : Google Scholar
|
|
25
|
Deng Y, Liao Q, Li S, Bi K, Pan B and Xie
Z: Simultaneous determination of berberine, palmatine and
jatrorrhizine by liquid chromatography-tandem mass spectrometry in
rat plasma and its application in a pharmacokinetic study after
oral administration of coptis-evodia herb couple. J Chromatogr B
Analyt Technol Biomed Life Sci. 863:195–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang JM, Wang GQ, Jin YE, Shen T and Weng
W: Determination of palmatine in canine plasma by liquid
chromatography-tandem mass spectrometry with solid-phase
extraction. J Chromatogr B Analyt Technol Biomed Life Sci.
854:279–285. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hua W, Ding L, Chen Y, Gong B, He J and Xu
G: Determination of berberine in human plasma by liquid
chromatography-electrospray ionization-mass spectrometry. J Pharm
Biomed Anal. 44:931–937. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pan GY, Wang GJ, Liu XD, Fawcett JP and
Xie YY: The involvement of P-glycoprotein in berberine absorption.
Pharmacol Toxicol. 91:193–197. 2002. View Article : Google Scholar
|
|
29
|
Zhang X, Qiu F, Jiang J, Gao C and Tan Y:
Intestinal absorption mechanisms of berberine, palmatine,
jateorhizine, and coptisine: Involvement of P-glycoprotein.
Xenobiotica. 41:290–296. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Xing D, Wang W, Lei F, Su H and Du
L: The uptake and transport behavior of berberine in Coptidis
Rhizoma extract through rat primary cultured cortical neurons.
Neurosci Lett. 379:132–137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Maeng HJ, Yoo HJ, Kim IW, Song IS, Chung
SJ and Shim CK: P-glycoprotein-mediated transport of berberine
across Caco-2 cell monolayers. J Pharm Sci. 91:2614–2621. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo Y, Li F, Ma X, Cheng X, Zhou H and
Klaassen CD: CYP2D plays a major role in berberine metabolism in
liver of mice and humans. Xenobiotica. 41:996–1005. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu Y, Hao H, Xie H, Lv H, Liu C and Wang
G: Oxidative demethylenation and subsequent glucuronidation are the
major metabolic pathways of berberine in rats. J Pharm Sci.
98:4391–4401. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Y, Ren G, Wang YX, Kong WJ, Yang P,
Wang YM, Li YH, Yi H, Li ZR, Song DQ and Jiang JD: Bioactivities of
berberine metabolites after transformation through CYP450
isoenzymes. J Transl Med. 9:622011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen X, Murawski A, Patel K, Crespi CL and
Balimane PV: A novel design of artificial membrane for improving
the PAMPA model. Pharm Res. 25:1511–1520. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Avdeef A and Testa B: Physicochemical
profiling in drug research: A brief survey of the state-of-the-art
of experimental techniques. Cell Mol Life Sci. 59:1681–1689. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hilgers AR, Conradi RA and Burton PS:
Caco-2 cell monolayers as a model for drug transport across the
intestinal mucosa. Pharm Res. 7:902–910. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Le Ferrec E, Chesne C, Artusson P, Brayden
D, Fabre G, Gires P, Guillou F, Rousset M, Rubas W and Scarino ML:
In vitro models of the intestinal barrier. The report and
recommendations of ECVAM Workshop 46 European Centre for the
Validation of Alternative methods. Altern Lab Anim. 29:649–668.
2001.PubMed/NCBI
|
|
39
|
Kerns EH, Di L, Petusky S, Farris M, Ley R
and Jupp P: Combined application of parallel artificial membrane
permeability assay and Caco-2 permeability assays in drug
discovery. J Pharm Sci. 93:1440–1453. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Artursson P, Palm K and Luthman K: Caco-2
monolayers in experimental and theoretical predictions of drug
transport. Adv Drug Deliv Rev. 46:27–43. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gu L, Li N, Li Q, Zhang Q, Wang C, Zhu W
and Li J: The effect of berberine in vitro on tight junctions in
human Caco-2 intestinal epithelial cells. Fitoterapia. 80:241–248.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Stenberg P, Norinder U, Luthman K and
Artursson P: Experimental and computational screening models for
the prediction of intestinal drug absorption. J Med Chem.
44:1927–1937. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Troutman MD and Thakker DR: Efflux ratio
cannot assess P-glycoprotein-mediated attenuation of absorptive
transport: Asymmetric effect of P-glycoprotein on absorptive and
secretory transport across Caco-2 cell monolayers. Pharm Res.
20:1200–1209. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Troutman MD and Thakker DR: Novel
experimental parameters to quantify the modulation of absorptive
and secretory transport of compounds by P-glycoprotein in cell
culture models of intestinal epithelium. Pharm Res. 20:1210–1224.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Polli JW, Wring SA, Humphreys JE, Huang L,
Morgan JB, Webster LO and Serabjit-Singh CS: Rational use of in
vitro P-glycoprotein assays in drug discovery. J Pharmacol Exp
Ther. 299:620–628. 2001.PubMed/NCBI
|
|
46
|
Bermejo M, Avdeef A, Ruiz A, Nalda R,
Ruell JA, Tsinman O, González I, Fernández C, Sánchez G, Garrigues
TM and Merino V: PAMPA - a drug absorption in vitro model 7.
Comparing rat in situ, Caco-2, and PAMPA permeability of
fluoroquinolones. Eur J Pharm Sci. 21:429–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Reis JM, Dezani AB, Pereira TM, Avdeef A
and Serra CH: Lamivudine permeability study: A comparison between
PAMPA, ex vivo and in situ Single-Pass Intestinal Perfusion (SPIP)
in rat jejunum. Eur J Pharm Sci. 48:781–789. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
U.S. Department of Health and Human
Services, Food and Drug Administration, Center for Drug Evaluation
Research (CDER) and Center for Veterinary Medicine (CVM): Guidance
for Industry. Bioanalytical Method Validation. 2001.
|
|
49
|
Tang YB: Quality by Design Approaches to
Analytical Methods - FDA Perspective. FDA/CDER. 2011.
|
|
50
|
Adson A, Burton PS, Raub TJ, Barsuhn CL,
Audus KL and Ho NF: Passive diffusion of weak organic electrolytes
across Caco-2 cell monolayers: Uncoupling the contributions of
hydrodynamic, transcellular, and paracellular barriers. J Pharm
Sci. 84:1197–1204. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cui HM, Zhang QY, Wang JL, Chen JL, Zhang
YL and Tong XL: In vitro studies of berberine metabolism and its
effect of enzyme induction on HepG2 cells. J Ethnopharmacol. 158(Pt
A): 388–396. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Pade V and Stavchansky S: Estimation of
the relative contribution of the transcellular and paracellular
pathway to the transport of passively absorbed drugs in the Caco-2
cell culture model. Pharm Res. 14:1210–1215. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mandagere AK, Thompson TN and Hwang KK:
Graphical model for estimating oral bioavailability of drugs in
humans and other species from their Caco-2 permeability and in
vitro liver enzyme metabolic stability rates. J Med Chem.
45:304–311. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kostewicz ES, Aarons L, Bergstrand M,
Bolger MB, Galetin A, Hatley O, Jamei M, Lloyd R, Pepin X,
Rostami-Hodjegan A, et al: PBPK models for the prediction of in
vivo performance of oral dosage forms. Eur J Pharm Sci. 57:300–21.
2014. View Article : Google Scholar
|
